INTC
Intel Corporation
INTC offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
PTRN
Pattern Group Inc. Series A Common Stock
PTRN has the edge over INTC overall, supported by lower modeled downside.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
PTRN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Stable | |
| Healthy |
PTRN's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
PTRN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 24x | $18.66 | -11% |
| Fair | 25x | $19.54 | -6.7% |
| Expensive | 27x | $20.44 | -2.5% |
| Current | 27x | $20.95 | — |
| Forward | 28x | $20.95 | — |
Historical ranges are pointers, not guarantees.
PTRN's PE is 27x, but its earnings don't support one, so it isn't a reliable read right now.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
Analysts expect earnings and revenue growth for INTC, with profitability improving. However, they disagree widely on these estimates.
PTRN Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for PTRN, with profitability improving.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
INTC has swung to a loss: it lost $2.39 per share over the past year, after a profit the year before.
PTRN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.76 | -1.3% |
| Q3 2026 | $0.77 | +$2.68 |
| Q2 2026 | -$1.60 | -544% |
| Q1 2026 | -$1.66 | -603% |
| Q4 2025 | -$1.73 | -658% |
| Q3 2025 | -$1.91 | -782% |
PTRN has the edge over INTC on earnings quality, reporting a profit while its opponent remains loss making.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC's revenue is recovering but still below its 2021 peak: $16.5B last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC has the edge over PTRN on profitability, with a higher operating margin.
PTRN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $885.8M | +38% |
| Q2 2026 | $876.8M | +47% |
| Q1 2026 | $773.7M | +43% |
| Q4 2025 | $723.1M | +40% |
| Q3 2025 | $639.7M | +46% |
| Q2 2025 | $598.2M | +39% |
| Q1 2025 | $540.4M | +32% |
| Q4 2024 | $515.5M | +31% |
PTRN has the edge over INTC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.2% | +14 points |
| Q2 2026 | 4% | -1 points |
| Q1 2026 | 5.1% | -0.3 points |
| Q4 2025 | 3.6% | -0.9 points |
| Q3 2025 | -9.4% | -13 points |
| Q2 2025 | 5% | -0.3 points |
| Q1 2025 | 5.4% | -0.2 points |
| Q4 2024 | 4.5% | +0.5 points |
PTRN's operating margin was 4.2% last quarter, up 14 points from the same quarter a year ago.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC's free cash flow has turned positive after four years mostly in the red: $3.8B over the past year.
PTRN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $3.8M | +$7.1M |
| Q1 2026 | $63.3M | +47% |
| Q2 2025 | -$3.3M | -1297% |
| Q1 2025 | $43.2M | +26% |
PTRN generated $106M in free cash flow over the past year, up 42% from the year before.
INTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4% | +203M shares |
| 1 year | +17% | +776M shares |
| 3 years | +25% | +1.1B shares |
| 5 years | +30% | +1.2B shares |
| Available history | +19% | +834M shares |
INTC has the edge over PTRN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $114M |
| Q1 2021 | $2.3B |
PTRN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +1.2M shares |
| 1 year | +79% | +80.7M shares |
PTRN has 182M diluted shares, up 79% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $18.4M |
| Q2 2026 | $94,000 |
| Q1 2026 | $3.6M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q2 2024 | — |
| Q1 2024 | — |
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
PTRN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.2x | Net Cash |
| Q2 2026 | -5.9x | Net Cash |
| Q1 2026 | -6.3x | Net Cash |
| Q4 2025 | -6.5x | Net Cash |
| Q3 2025 | -7.3x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.7x | Net Cash |
PTRN has the edge over INTC on leverage, with a lower net debt burden relative to earnings.
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
PTRN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.7 | Neutral |
| Stochastic | 36.8 | Neutral |
PTRN's weekly RSI is 56 (neutral) and its Stochastic is 37 (neutral).
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
PTRN PE vs Technology Sector
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
PTRN has stronger trend alignment. INTC is above 2 of 5 weekly averages versus PTRN above 3 of 3.
PTRN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.8 | 18% above |
| 20 week MA | $20.8 | 0.7% above |
| 50 week MA | $16.9 | 24% above |
PTRN is in an uptrend: it's above all three of its weekly moving averages, and 24% above its 50-week average.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC is up 69% so far in 2026, after finishing lower in three of the previous six years.
PTRN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $15.6 | $11.8 | -24% |
| 2026 YTD | $11.8 | $21.0 | +77% |
PTRN has the edge over INTC on returns for 2026, with the stronger performance.